Eucalyptol
Overview
Ipriflavone is a synthetic isoflavonoid that inhibits reabsorption of bone. Ipriflavone is given by mouth and is available for the treatment of osteoporosis.
Categories
- 25 Drugs acting on the respiratory tract
- 25 Drugs acting on the respiratory tract
Primary Characterstics
Indications
Back to top
Pharmacokinetics
Back to top
Contraindications
Back to top
Back to top
Side Effects
Back to top
Dosage
Eucalyptol's dosage details are as follows:
| Dose
|
Single Dose
|
Frequency
|
Route
|
Instructions
|
Adult Dosage
|
| 0.3 to 0.6 gm | 0.45 (0.45) | 24 hourly | | |
| 0.05 to 0.2 ml | 0.12 (0.125) | As recommended. | Oral | |
| 46 to 84 mg | 65 (65) | As recommended. | Oral | |
Paedriatic Dosage (20kg)
|
| No data regarding the Paedriatic dosage details of Eucalyptol is available. |
Neonatal Dosage (3kg)
|
| No data regarding the neonatal dosage details of Eucalyptol is available. |
High Risk Groups
Back to top
Warning / Precautions
Back to top
Storage Conditions
Back to top
Interference in Pathology
Back to top
Brands / Trade Names of
Eucalyptol
Back to top
Previous Drug Generic - Next Drug Generic